Standalone Laboratories
A dedicated laboratory information system for independent diagnostic laboratories.
Patient overview
Synthetic dataAN
Amaka Nwosu
InpatientHN 2026/00871 · Female, 34
Clinical encounter
Ward 3B · Bed 12
Review documentedClinical notes and observationsLaboratory
Full blood count
Results availableValidated laboratory reportPharmacy
Medication orders
Dispensing recordedPrescribed and dispensed historyBilling
Service records
Payment status availableAmounts restricted by roleIllustrative interface · Under development
The Platform
A unified system for clinical and administrative operations.
Patient Records
Under development- Patient registration
- Clinical encounters
- Clinical documentation
- Longitudinal patient history
- Unified patient records
Patients · Amaka Nwosu · Unified record
Interface preview · synthetic data
AN
Amaka Nwosu
Allergy: Penicillin
Blood group O+
Admitted 4 Jul · Post-op day 5
Medications
Prescribed and dispensed →| Prescribed | Ordered by | Dispensed | Status |
|---|---|---|---|
Metformin 1 g BD Regular, continued on admission |
Dr E. Adeniyi | Metformin 1 g BD Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Metronidazole 400 mg TDS 4 Jul 19:10 |
Dr E. Adeniyi | →Tinidazole 500 mg BD Pharm. T. Ojo, 4 Jul 19:44 |
Substituted · out of stock |
Enoxaparin 40 mg OD SC VTE prophylaxis, 4 Jul 20:00 |
Dr E. Adeniyi | Enoxaparin 40 mg OD SC Pharm. T. Ojo, 4 Jul 20:15 |
Dispensed as prescribed |
Nitrofurantoin 100 mg QDS Culture-directed, 6 Jul 14:05 |
Dr E. Adeniyi | Nitrofurantoin 100 mg QDS Pharm. T. Ojo, 6 Jul 15:20 |
Dispensed as prescribed |
Paracetamol 1 g TDS PRN 4 Jul 19:10 |
Dr E. Adeniyi | Paracetamol 1 g TDS PRN Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Health Scope records what the patient actually received, not only what was written. Substitutions, holds and stock-outs are captured against the same record.
Investigations
All results →Full blood count8 Jul
WBC 9.4 ×10⁹/L, falling · Hb 10.8 g/dL · Plt 361
Fasting blood glucose9 Jul
6.8 mmol/L · HbA1c 7.2% (Jun)
Urea & electrolytes8 Jul
Within reference range
Urine culture & sensitivity6 Jul
Escherichia coli · >10⁵ cfu/mL Resistance flagged
RCiprofloxacin
SNitrofurantoin
Chest radiograph4 Jul
Pre-operative · no acute cardiopulmonary abnormality
Vitals
9 Jul, 06:00Temp
37.1°C
BP
118/76
Pulse
96bpm
Clinical note
9 Jul, 08:22Day 5 post-laparotomy. Comfortable overnight, pain controlled on oral analgesia. Mobilising to the corridor with one nurse, tolerating a soft diet. Wound clean and dry, staples intact. Glycaemic control steady on her usual metformin. Nitrofurantoin continues for the urinary isolate. For discharge planning review on Friday.
Dr E. Adeniyi · Registrar, General Surgery · signed 08:31
Diagnoses & alerts
Type 2 diabetes mellitus
Diagnosed 2021 · metformin 1 g BD
Post-operative recovery
Day 5 · wound healing by primary intention
Penicillin allergy
Urticarial rash, documented 2019
Procedures
Full history →Exploratory laparotomy
4 Jul 2026 · Theatre 2 · Mr O. Balogun
Wound review, staples checked
7 Jul 2026 · bedside · Nurse F. Adeyemi
Caesarean section
2019 · uncomplicated
Payments
Role: ClinicianConsultationPaid
Laboratory, 6 investigationsPaid
Pharmacy, dispensed to datePaid
Theatre & proceduresPaid
Repeat full blood count, requested 9 JulNot paid
Amounts, invoices and claims are visible to billing and administration roles only.
Interface preview · synthetic data
AN
Amaka Nwosu
Allergy: Penicillin
Blood group O+
Admitted 4 Jul · Post-op day 5
Diagnoses & alerts
Type 2 diabetes mellitus
Diagnosed 2021 · metformin 1 g BD
Post-operative recovery
Day 5 · wound healing by primary intention
Penicillin allergy
Urticarial rash, documented 2019
Clinical note
9 Jul, 08:22Day 5 post-laparotomy. Comfortable overnight, pain controlled on oral analgesia. Mobilising to the corridor with one nurse, tolerating a soft diet. Wound clean and dry, staples intact. Glycaemic control steady on her usual metformin. Nitrofurantoin continues for the urinary isolate. For discharge planning review on Friday.
Dr E. Adeniyi · Registrar, General Surgery · signed 08:31
| Prescribed | Ordered by | Dispensed | Status |
|---|---|---|---|
Metformin 1 g BD Regular, continued on admission |
Dr E. Adeniyi | Metformin 1 g BD Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Metronidazole 400 mg TDS 4 Jul 19:10 |
Dr E. Adeniyi | →Tinidazole 500 mg BD Pharm. T. Ojo, 4 Jul 19:44 |
Substituted · out of stock |
Enoxaparin 40 mg OD SC VTE prophylaxis, 4 Jul 20:00 |
Dr E. Adeniyi | Enoxaparin 40 mg OD SC Pharm. T. Ojo, 4 Jul 20:15 |
Dispensed as prescribed |
Nitrofurantoin 100 mg QDS Culture-directed, 6 Jul 14:05 |
Dr E. Adeniyi | Nitrofurantoin 100 mg QDS Pharm. T. Ojo, 6 Jul 15:20 |
Dispensed as prescribed |
Paracetamol 1 g TDS PRN 4 Jul 19:10 |
Dr E. Adeniyi | Paracetamol 1 g TDS PRN Pharm. T. Ojo, 4 Jul 19:40 |
Dispensed as prescribed |
Health Scope records what the patient actually received, not only what was written. Substitutions, holds and stock-outs are captured against the same record.
Full blood count8 Jul
WBC 9.4 ×10⁹/L, falling · Hb 10.8 g/dL · Plt 361
Fasting blood glucose9 Jul
6.8 mmol/L · HbA1c 7.2% (Jun)
Urea & electrolytes8 Jul
Within reference range
Urine culture & sensitivity6 Jul
Escherichia coli · >10⁵ cfu/mL Resistance flagged
RCiprofloxacin
SNitrofurantoin
Chest radiograph4 Jul
Pre-operative · no acute cardiopulmonary abnormality
Temp
37.1°C
BP
118/76
Pulse
96bpm
Exploratory laparotomy
4 Jul 2026 · Theatre 2 · Mr O. Balogun
Wound review, staples checked
7 Jul 2026 · bedside · Nurse F. Adeyemi
Caesarean section
2019 · uncomplicated
ConsultationPaid
Laboratory, 6 investigationsPaid
Pharmacy, dispensed to datePaid
Theatre & proceduresPaid
Repeat full blood count, requested 9 JulNot paid
Amounts, invoices and claims are visible to billing and administration roles only.
Patient-record interface preview · Synthetic data · Under development
Laboratory Management
Initial development focusHaematologyBlood Bank & Transfusion ScienceChemical Pathology / Clinical ChemistryHistopathology & CytopathologyMedical Microbiology & Parasitology
Manage test requests, specimen tracking, results validation, and reporting, including culture and antimicrobial susceptibility testing.
Illustrative laboratory workflow · Under development
Test requestSpecimen trackingValidationResults & reports
Pharmacy Management
Under development- Prescriptions and medication orders
- Dispensing
- Drug inventory and stock management
- Medication history
- Antibiotic consumption tracking
Medication orders, dispensing records, and stock information within the patient workflow.
Billing & HMO
Under development- Service charges
- Invoicing and payments
- Billing records
- Insurance-related workflows
Planned HMO capabilities
Eligibility and authorization; claims preparation, filing, and tracking. These integrations are not yet operational.
Clinical Intelligence
Interactive demonstrations available below- Facility-specific antibiograms
- Antimicrobial resistance trends
- Antibiotic consumption analytics
Future roadmap
Infection surveillance, early warning, and predictive resistance analytics.
Clinical Intelligence
Explore facility-specific antibiograms, antimicrobial resistance trends, and antibiotic consumption data to support antimicrobial stewardship.
Interactive demonstrations · Synthetic data, not live facility results
Analytics · Facility antibiogram
Demo · synthetic data
Drug susceptibility
S I RPrevalence ranking
Synthetic first-isolate counts. Select an organism to view its susceptibility panel.
Indication filters change organism prevalence; susceptibility remains organism-wide. Demonstration only, not a treatment guide.
Resistance Trends
Percentage of tested isolates reported resistant, by quarter.
Ceftriaxone · Synthetic demonstration data
Illustrative trends only. Rates use the number of isolates tested against this agent as the denominator.
Antibiotic Use
Illustrative dispensing activity across a facility.
Dispensing events · Synthetic demonstration data
A dispensing event is a recorded supply transaction, not a dose or a patient count. Consumption alone does not establish the cause of observed resistance.
Expanding toward infection surveillance and predictive resistance analytics.
Deployment Options
HealthScope can be deployed according to a facility's existing systems and operational needs.
Hospitals with an Existing HIS
Deploy HealthScope's LIS alongside an existing hospital system, with integration where supported.
Full Hospital Deployment
Adopt HealthScope as the hospital's primary information system across clinical and administrative departments.
Deployment configurations reflect the development direction. Availability and integration support are assessed for each facility.
About HealthScope
HealthScope is a healthcare technology initiative developing hospital information systems with integrated clinical intelligence. Our work brings together healthcare expertise, clinical research, and software engineering to develop technology that addresses the practical needs of healthcare delivery.
Development
HealthScope is under active development, with initial work focused on laboratory information management and the foundation for a broader hospital information system.
Research & Collaboration
Our approach is informed by clinical practice and antimicrobial resistance research, with an interest in improving the use of routine healthcare data for surveillance.
Get in touch
For enquiries, collaborations, or discussions about HealthScope, contact us.